How to Identify Invisible Ischemia with Nihon Kohden Technologies: SynECi18
Picture this situation!
A patient walks into the ER complaining of fatigue and chest pain. The patient was sent home after the ER nurses perform the standard 12 lead ECG and found no abnormalities in the results. After a period of time, the patient’s case deteriorates, and is brought back to the hospital. Further investigation reveals that this patient was suffering from a posterior infarction that was inconclusive during the 12 lead ECG diagnosis.
At Nihon Kohden, we offer the lifesaving solution of #SynECi18 By incorporating six additional leads (V3R, V4R, V5R, V7, V8, and V9), using our advanced algorithms and signal processing #technology to ensure accurate, high-quality readings, enabling #clinicians to make more informed decisions about patient care
This enhanced visibility enables healthcare professionals to detect and diagnose conditions that may be missed by a standard 12-lead ECG, such as posterior and right ventricular infarctions.
Nihon Kohden Middle East contributes to the world by fighting disease and improving health with advanced technology.